Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
508,509 Lumasiran, a siRNA drug that targets hydroxy acid oxidase 1 to reduce hepatic oxalate production, was the first drug approved for PH1
au bng l mt trong nhng tc dng ph c th xy ra khi s dng glutathione 6Nhng iu cn bit trc khi s dng Glutathione Trc khi s dng glutathione, bn nn hi kin ca bc s nu ang gp nhng trng hp sau: ang mang thai hoc cho con b trnh nh hng xu n m v con
/ WellsPharmtech Co., Ltd
A Supramolecular Janus hyperbranched polymer and its photoresponsive self-assembly of vesicles with narrow size distribution
US$ 20.14
US$ 25.56
.png)
US$ 20.77
US$ 29.47
US$ 25.36
US$ 27.54
US$ 26.57
